Your browser doesn't support javascript.
loading
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.
Naito, Yoichi; Mishima, Saori; Akagi, Kiwamu; Igarashi, Ataru; Ikeda, Masafumi; Okano, Susumu; Kato, Shunsuke; Takano, Tadao; Tsuchihara, Katsuya; Terashima, Keita; Nishihara, Hiroshi; Nishiyama, Hiroyki; Hiyama, Eiso; Hirasawa, Akira; Hosoi, Hajime; Maeda, Osamu; Yatabe, Yasushi; Okamoto, Wataru; Ono, Shigeru; Kajiyama, Hiroaki; Nagashima, Fumio; Hatanaka, Yutaka; Miyachi, Mitsuru; Kodera, Yasuhiro; Yoshino, Takayuki; Taniguchi, Hiroya.
Afiliação
  • Naito Y; Department of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. ynaito@east.ncc.go.jp.
  • Mishima S; Japanese Society of Medical Oncology (JSMO), Tokyo, Japan. ynaito@east.ncc.go.jp.
  • Akagi K; Department of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Igarashi A; Japan Society of Clinical Oncology (JSCO), Tokyo, Japan.
  • Ikeda M; Saitama Cancer Center, Saitama, Japan.
  • Okano S; Japanese Society of Medical Oncology (JSMO), Tokyo, Japan.
  • Kato S; Yokohama City University School of Medicine, Yokohama, Japan.
  • Takano T; Japan Society of Clinical Oncology (JSCO), Tokyo, Japan.
  • Tsuchihara K; Department of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Terashima K; Japan Society of Clinical Oncology (JSCO), Tokyo, Japan.
  • Nishihara H; Department of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Nishiyama H; Japan Society of Clinical Oncology (JSCO), Tokyo, Japan.
  • Hiyama E; Juntendo University, Tokyo, Japan.
  • Hirasawa A; Japanese Society of Medical Oncology (JSMO), Tokyo, Japan.
  • Hosoi H; Tohoku University, Sendai, Japan.
  • Maeda O; Japan Society of Clinical Oncology (JSCO), Tokyo, Japan.
  • Yatabe Y; Department of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
  • Okamoto W; Japan Society of Clinical Oncology (JSCO), Tokyo, Japan.
  • Ono S; National Center for Child Health and Development, Tokyo, Japan.
  • Kajiyama H; Japan Society of Clinical Oncology (JSCO), Tokyo, Japan.
  • Nagashima F; Keio University, Tokyo, Japan.
  • Hatanaka Y; Japanese Society of Medical Oncology (JSMO), Tokyo, Japan.
  • Miyachi M; Tsukuba University, Ibaraki, Japan.
  • Kodera Y; Japan Society of Clinical Oncology (JSCO), Tokyo, Japan.
  • Yoshino T; Hiroshima University Hospital, Hiroshima, Japan.
  • Taniguchi H; Japan Society of Clinical Oncology (JSCO), Tokyo, Japan.
Int J Clin Oncol ; 25(3): 403-417, 2020 Mar.
Article em En | MEDLINE | ID: mdl-31974683

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Proteína Tirosina Quinases / Inibidores de Proteínas Quinases / Neoplasias / Antineoplásicos Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Adult / Child / Humans País/Região como assunto: Asia Idioma: En Revista: Int J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Proteína Tirosina Quinases / Inibidores de Proteínas Quinases / Neoplasias / Antineoplásicos Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Adult / Child / Humans País/Região como assunto: Asia Idioma: En Revista: Int J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão